Patent · US Active

Methods of treatment with Syk inhibitors

US8057815B2 · kind B2 · utility

1Cited by
1References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 15, 2005
Grant dateNov 15, 2011
Priority date
Expiry dateSep 27, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/434
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel compositions and methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient undergoing a vascular intervention. More particularly, the present invention provides intravascular devices coated with one or more spleen tyrosine kinase (Syk) inhibitors. Methods for inhibiting restenosis, thrombosis, and/or inflammation in a patient by treatment with such intravascular devices are also provided. In addition, the present invention provides methods for treating sickle cell disease using Syk inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.